MSB11456

· Fresenius Kabi SwissBioSim GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSB11456, covering 2022-10-24 to 2022-10-24. Get the full timeline:

Most recent: Clinical Trial Update: MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis [Phase 3]